![]() |
市场调查报告书
商品编码
1383307
到 2030 年的全球二氧化碳图设备市场预测:按产品、技术、应用、最终用户和地区进行分析Capnography Equipment Market Forecasts to 2030 - Global Analysis By Product, By Technology, By Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球二氧化碳监测设备市场规模为 3.781 亿美元,预计在预测期内年复合成长率为 6.4%,到 2030 年达到 5.837 亿美元。
二氧化碳图设备市场包括用于监测和检测患者呼出气中二氧化碳 (CO2) 浓度的设备,通常在医疗手术和呼吸监测期间使用。二氧化碳图设备在各种临床环境中至关重要,透过提供患者呼吸状态的即时回馈来确保患者安全。其好处包括及早发现通气不足、气道阻塞和其他呼吸系统问题。
据疾病预防和健康促进办公室称,美国有超过 2500 万人患有气喘。
随着外科手术变得越来越普遍和复杂,在给药期间准确、即时监测患者呼吸状态的需求变得至关重要。二氧化碳图设备提供口腔二氧化碳水平的连续资料,使医疗专业人员能够快速检测和解决潜在的呼吸系统问题,包括通气不足和气道问题。我会做到的。随着一般外科、整形外科、腹腔镜手术等各专科手术需求的不断增加,二氧化碳图设备的需求量激增,以确保手术过程中病患的安全和最佳效果,它已成为不可或缺的工具。
二氧化碳图设备需要正确的设定、校准和维护,以提供准确可靠的呼吸监测。缺乏合格的人员来操作和维护这些设备可能会导致使用效果不佳、资料误解并降低患者安全。医疗设备很复杂,需要专门的培训,这带来了挑战,特别是在面临人员短缺的医疗机构中。为了解决这一限制,投资于培训计划、使用者友好介面和远端支援服务将提高医疗保健专业人员的能力,增强二氧化碳图设备的有效使用,并最终患者照护。
随着医学界不断认识到二氧化碳图在患者照护中的价值,越来越多的研究和临床研究正在进行中,为其有效性提供了坚实的证据。这些证据的累积支持二氧化碳图在各种医疗环境中的使用,包括手术、急诊医学和重症医学。医疗保健提供者和机构可以利用这项研究就将二氧化碳图设备纳入其实践做出更资讯的决策。宣传二氧化碳图的好处,提高普及,并确保改善患者的治疗效果,同时增加市场成长机会。
由于政府法规和核准流程因地区而异,製造商面临着应对复杂环境的挑战。严格的要求和不明确的法规指南导致产品开发和市场进入的延迟,增加了合规成本和上市时间。法规模糊也可能导致产品核可的误解和不一致,从而阻碍市场成长和创新。这种威胁导致人们关注法规合规性和透明度,以及行业协作,以简化和标准化核准流程,确保及时有效地引入二氧化碳图设备,同时保持高安全标准。
COVID-19 大流行对二氧化碳图设备市场产生了重大影响。这种病毒对呼吸系统的影响导致对二氧化碳图设备的需求激增,特别是在重症监护和紧急情况下。二氧化碳图在监测 COVID-19 患者的呼吸状态方面发挥了重要作用,尤其是那些使用人工呼吸器的患者。这次疫情凸显了早期发现呼吸窘迫的重要性,并加速了二氧化碳图设备的采用。然而,供应链中断和医疗资源紧张也是问题。虽然市场需求增加,但由于医疗机构优先考虑呼吸监测,製造和分销面临障碍。这场大流行再形成了二氧化碳图设备的格局,并凸显了其在现代医学中的作用。
独立设备预计将占据二氧化碳图设备市场的很大份额。这些设备被设计为专用的独立装置,用于即时监测患者的吐气末二氧化碳水平。它自主运行,使其具有高度通用性,适用于各种临床环境。独立二氧化碳图设备广泛用于急诊室、加护病房、手术室和病人转运过程。其便携性和易用性使其成为持续呼吸监测的宝贵工具。用于监测和改善呼吸功能的最新医疗设备在检测通气不足和插管问题等呼吸问题以及确保患者安全和最佳护理方面发挥着至关重要的作用,已成为不可或缺的一部分。
预计医院部门在预测期内将以最有效的速度成长。这些医疗机构广泛使用二氧化碳图设备来持续监测患者的吐气末二氧化碳浓度。在医院,二氧化碳图被整合到急诊室、手术室、加护病房和普通病房等各个部门。该设备有助于早期发现呼吸系统併发症,确保及时介入并提高患者安全。它在麻醉管理、机械通气和重症监护情况下非常有效。医院依靠二氧化碳图设备来加强呼吸评估、监测镇静患者并确保最佳呼吸功能,使其成为现代医学的重要工具。
在预测期内,由于其成熟的医疗部门、对病人安全的重视和先进的医疗技术,北美二氧化碳监测设备市场预计将占据大部分市场占有率。该地区的医疗机构,包括医院和门诊手术中心,正在优先考虑二氧化碳监测仪,因为它在早期发现呼吸系统併发症方面发挥着重要作用。随着呼吸系统疾病盛行率的不断增加,人们对二氧化碳图重要性的认识不断提高,推动了北美对二氧化碳图设备的需求,并对全球市场做出了重大贡献。
由于人们越来越认识到二氧化碳图监测在医疗保健中的重要性,预计亚太地区在预测期内将出现最高的年复合成长率。该地区对先进医疗技术和改善患者照护的需求不断增长。二氧化碳图是监测吐气末二氧化碳水平和呼吸功能的重要工具,广泛应用于重症监护、麻醉和急诊医学。随着医疗保健基础设施的改善,二氧化碳图设备的采用越来越多,以确保病人安全和早期发现呼吸系统问题。此外,亚太地区高龄化和呼吸系统疾病的流行进一步促进了亚太地区二氧化碳监测设备市场的扩张。
According to Stratistics MRC, the Global Capnography Equipment Market is accounted for $378.1 million in 2023 and is expected to reach $583.7 million by 2030 growing at a CAGR of 6.4% during the forecast period. The Capnography Equipment Market encompasses devices used to monitor and measure the concentration of carbon dioxide (CO2) in a patient's exhaled breath, typically during medical procedures or respiratory monitoring. Capnography equipment is essential in various clinical settings, ensuring patient safety by providing real-time feedback on their respiratory status. Its advantages include early detection of hypoventilation, airway obstructions, or other respiratory issues.
According to the office of disease prevention and health promotion, more than 25 million people in the USA are suffering from Asthma.
As surgical procedures become more common and complex, the need for accurate and real-time monitoring of patients' respiratory status during anesthesia administration is paramount. Capnography equipment provides continuous data on end-tidal carbon dioxide levels, enabling healthcare professionals to swiftly detect and address potential respiratory issues, including hypoventilation and airway problems. With the rising demand for surgical interventions across various medical specialties, such as general surgery, orthopedics, and laparoscopy, the demand for capnography equipment has surged, making it an indispensable tool to ensure patient safety and optimal outcomes during surgery.
Capnography devices require proper setup, calibration, and maintenance to ensure accurate and reliable respiratory monitoring. A lack of qualified personnel to operate and maintain these instruments can result in suboptimal usage, misinterpretation of data, and decreased patient safety. The complexity of medical equipment and the need for specialized training can create challenges, particularly in healthcare settings facing staff shortages. To address this restraint, investment in training programs, user-friendly interfaces, and remote support services can empower healthcare professionals and enhance the effective use of capnography equipment, ultimately improving patient care.
As the medical community continues to recognize the value of capnography in patient care, more research and clinical studies are conducted, providing robust evidence of its efficacy. This growing body of evidence strengthens the case for capnography's use in various medical settings, including surgery, emergency care, and critical care. Healthcare providers and institutions can leverage this research to make more informed decisions about integrating capnography equipment into their practices. The opportunity lies in promoting the benefits of capnography, driving greater adoption, and ensuring improved patient outcomes while enhancing the market's growth prospects.
Government regulations and approval procedures vary across regions, making it challenging for manufacturers to navigate the complex landscape. Stringent requirements and unclear regulatory guidelines can lead to delays in product development and market entry, increasing compliance costs and time-to-market. Ambiguities in regulations may also result in misinterpretations and inconsistencies in product approvals, hindering market growth and innovation. This threat necessitates a strong focus on regulatory compliance and transparency, as well as industry collaboration to streamline and standardize approval processes, ensuring the timely and efficient introduction of capnography equipment while maintaining high safety standards.
The COVID-19 pandemic had a significant impact on the Capnography Equipment Market. With the virus's respiratory implications, the demand for capnography equipment surged, particularly in the critical care and emergency settings. Capnography played a crucial role in monitoring the respiratory status of COVID-19 patients, especially those on ventilators. The pandemic underscored the importance of early detection of respiratory distress, driving the adoption of capnography devices. However, supply chain disruptions and the strain on healthcare resources also presented challenges. As healthcare facilities prioritized respiratory monitoring, the market experienced increased demand, but manufacturing and distribution faced obstacles. The pandemic reshaped the landscape of capnography equipment, emphasizing its role in modern healthcare.
Stand-alone in the Capnography Equipment Market is expected to hold a significant share. These devices are designed as dedicated, independent units that provide real-time monitoring of end-tidal carbon dioxide levels in patients. They operate autonomously, making them versatile and applicable in various clinical settings. Stand-alone capnography equipment is widely used in emergency rooms, intensive care units, operating rooms, and during patient transport. Their portability and ease of use make them valuable tools for continuous respiratory monitoring. They play a critical role in detecting respiratory issues, such as hypoventilation and intubation problems, ensuring patient safety and optimal care, and are an integral part of modern healthcare equipment for monitoring and improving respiratory function.
During the anticipated period, the hospitals segment is expected to increase at the most effective rate. These medical facilities extensively utilize capnography equipment for continuous monitoring of patients' end-tidal carbon dioxide levels. In hospitals, capnography is integrated into various departments, including emergency rooms, operating rooms, intensive care units, and general wards. The equipment aids in the early detection of respiratory complications, ensuring timely intervention and improving patient safety. It is instrumental during anesthesia administration, mechanical ventilation, and critical care scenarios. Hospitals rely on capnography equipment to enhance respiratory assessment, monitor sedated patients, and ensure optimal respiratory function, making it an indispensable tool for modern healthcare.
During the forecast period, it is expected that the North American Capnography Equipment market will hold a majority of the market share driven by its well-established healthcare sector and a strong emphasis on patient safety and advanced medical technologies. The region's healthcare facilities, including hospitals and ambulatory surgery centers, prioritize Capnography for its role in early detection of respiratory complications. The growing awareness of the importance of Capnography, along with the increasing prevalence of respiratory conditions, propels the demand for Capnography equipment in North America, making it a significant contributor to the global market.
Asia Pacific is projected to have the highest CAGR over the forecast period driven by increasing awareness of the significance of capnography monitoring in healthcare. The region experiences a growing demand for advanced medical technologies and improved patient care. Capnography, a vital tool for monitoring end-tidal carbon dioxide levels and respiratory function, is extensively used in critical care, anaesthesia, and emergency medicine. As healthcare infrastructure improves, the adoption of Capnography equipment for patient safety and early detection of respiratory issues is on the rise. Additionally, the region's aging population and the prevalence of respiratory conditions further contribute to the expansion of the Capnography Equipment Market in Asia Pacific.
Some of the key players in Capnography Equipment market include: Diamedica Ltd., Dragerwerk AG & Co. KGaA, Koninklijke Philips N.V., Bionics, BPL Medical Technologies, Burtons Medical Equipment Ltd., Criticare Technologies Inc., Masimo, Edan Instruments, Inc., GE Healthcare, Hamilton Medical, Nihon Kohden Corp., Medtronic, Mindray Medical, ZOLL Medical, Nonin Medical, Inc., Smiths Medical and Welch Allyn (Hill-Rom Holdings, Inc.).
In November 2022, Masimo received U.S.FDA approval for NOMOLINE capnography sampling lines having more than 40 configurations of airway adapter sets and cannulas which can be used for both intubated and non- intubated patients and various other medical scenarios.
In October 2022, Masimo and Royal Philips, both global pioneers in patient monitoring, announced that they have strengthened their cooperation, with Philips integrating additional Masimo measurement technologies into certain IntelliVue MX-series multiparameter monitors to assist clinicians in assessing cerebral oximetry and ventilation status.
In June 2022, Nonin launched its next-generation LIFESENSE II and RESPONSE II Stand-Alone Capnometers, with high accuracy, ease of use, cost-effectiveness and having a wide range of applications.